Well done Ben.
Just dug deeper and found that one of 3DMs service offerings is "Visualise" an exclusive Australia and New Zealand arrangement with EchoPixel based in the USA. This technology allows 3D holographic imaging of anatomical parts for pre surgery.
Echopixel has secured US FDA 501k approval to operate as a medical device with substantial equivalence, which is on par or better than the reference benchmark tested. This is great news for 3DM having a exclusive access in Australia and NZ.
3DM will then also apply with the TGA (Australia) and Medsafe (NZ) to classify this device for medical use.
www.accessdata.fda.gov/cdrh_docs/pdf14/K142107.pdf
- Forums
- ASX - By Stock
- 3DM
- break through 14c is the next target
break through 14c is the next target, page-76
Featured News
Add 3DM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online